doi: 10.3389/fendo.2023.1178486 Received 02 March 2023 Accepted 09 June 2023 Published 04 July 2023 Volume 14 - 2023 Edited by Goo Jun, University of Texas Health Science Center at Houston, United States Reviewed by Pik Fang Kho, Stanford University, United States
PDRN (polydeoxyribonucleotide) activates dermal adenosine A2A receptors to drive fibroblast activity, angiogenesis, and anti-melanogenesis
Second, EtOH exposure, especially when chronic, reduces the antioxidant capacity of the liver and blood, as reflected by decreased levels of antioxidants (e.g
This powerful antioxidant encourages your body to produce an antioxidant of its own, glutathione, which helps mitigate the damage caused by heavy metal toxicity